Whole Body Cryotherapy and Hyperbaric Oxygen Treatment: New Biological Treatment of Depression? A Systematic Review
Krzystanek M, Romańczyk M, Surma S, Koźmin-Burzyńska A
Pharmaceuticals (Basel, Switzerland) · 1 cita
Cómo se estudió
- Diseño
- Revisión sistemática (clasificado por nuestro filtro de IA)
- Estudiado en
- Personas
- Resultado principal
- Marcadores de salud y funcionamiento
Quién lo pagó
- Financiación
- Financiación independiente
Según la declaración de financiación del texto completo.
Publicación
- Publicado
- 2021-06-21 · Pharmaceuticals (Basel) · vol. 14 · número 6 · pág. 595
- Editorial
- Multidisciplinary Digital Publishing Institute
- Citado
- 11 citas · más que el 26% de estudios similares · 0.1× el promedio de su campo
- Referencias
- 29 trabajos
- Acceso
- Acceso abierto (revista) · CC-BY
- Áreas de investigación
- Tryptophan and brain disorders · Fibromyalgia and Chronic Fatigue Syndrome Research · Genetic Neurodegenerative Diseases
- Palabras clave
- Depression (economics), Medicine, Antidepressant, Intensive care medicine, Cryotherapy, Pharmacotherapy, Clinical trial, Psychiatry, Internal medicine, Surgery, Anxiety
4 autores
- Marek Krzystanek🇵🇱 · autor de correspondenciaMedical University of Silesia; University of Silesia in Katowice
- Monika Romańczyk🇵🇱Medical University of Silesia; University of Silesia in Katowice
- Stanisław Surma🇵🇱Medical University of Silesia; University of Silesia in Katowice
- Agnieszka Koźmin-Burzyńska🇵🇱Medical University of Silesia
Resumen
El texto original del estudio, en el idioma en que se publicó.
Treatment with antidepressants is often insufficiently effective, especially in treatment-resistant depression. In such a situation, it is possible to change the drug, add a second antidepressant, or use pharmacological and non-pharmacological methods of augmenting the effect of pharmacotherapy. New methods that may fall into the scope of multi-module depression treatment as an augmentation of depression treatment are whole body cryotherapy (WBC) and hyperbaric oxygen treatment (HBOT). 545 records were selected and analyzed for these two treatments and finally three clinical trials were selected for analysis. The review also includes data on the possibility of using WBC and HBOT in somatic indications and in organic mental syndromes. Despite the small number of studies on the effectiveness of WBC or HBOT in depression, the current data show that both methods may be effective in the treatment of depression. WBC may be effective in the augmentation of antidepressants, and additionally, it is a method in which a quick antidepressant effect is obtained. HBOT may be effective in endogenous depression, just as it is effective in the treatment of somatic depression symptoms. The results are very preliminary, but if confirmed in subsequent studies, both WBC and HBOT may become new treatment options in treating depression. The authors point to the need and directions for further research into these treatment methods as an augmentation strategy for pharmacological treatment of depression.
Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial (CC BY).
Confianza de la comunidad
Cargando…
¿Cuánto confías en los hallazgos de este estudio?
Comentarios
¿Algo está mal aquí?
Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.
Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.